Treatment and Prevention Strategies for Skin Cancer
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Dermatology".
Deadline for manuscript submissions: closed (31 May 2021) | Viewed by 2858
Special Issue Editors
Interests: wound healing; cutaneous oncology; epidemiology
Special Issue Information
Dear Colleagues,
Skin cancer is the most common malignancy worldwide. There were over 77,000 new cases of melanoma diagnosed in the United States from 2012 to 2016. Nonmelanoma skin cancer (NSMC) is even more prevalent, with estimates of over 5.4 million new cases and over 3.3 million people treated in 2012. The rising incidence is attributed to aging population trends, increased cumulative UV exposure over lifetime, and immunosenescence. It is a public health concern as it is the fifth most costly cancer to treat. As we approach a greater understanding of its pathophysiology, a number of new therapies have emerged, including targeted treatments and immunotherapy. However, the prevention of skin cancer remains imperative, our current understanding being that the environmentally driven UV component of sunlight is the major risk factor. In this Special Issue, we hope to elucidate new treatment and prevention strategies for skin cancer.
Dr. Robert S. Kirsner
Dr. Jennifer C. Tang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- basal cell carcinoma
- squamous cell carcinoma
- melanoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
